BK VIREMIA; BKV DNAEMIA

Clinical trials for BK VIREMIA; BKV DNAEMIA explained in plain language.

Never miss a new study

Get alerted when new BK VIREMIA; BKV DNAEMIA trials appear

Sign up with your email to follow new studies for BK VIREMIA; BKV DNAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New drug fights dangerous virus in transplant patients

Disease control Completed

This study tested a new drug called AntiBKV to see if it could safely reduce BK virus levels in the blood of kidney transplant recipients. The virus can damage the new kidney. 95 participants received either the drug or a placebo through four IV infusions over several months. Res…

Matched conditions: BK VIREMIA; BKV DNAEMIA

Phase: PHASE2, PHASE3 • Sponsor: Memo Therapeutics AG • Aim: Disease control

Last updated Apr 02, 2026 05:42 UTC

BK VIREMIA; BKV DNAEMIA

Get alerted when new BK VIREMIA; BKV DNAEMIA trials appear

New drug fights dangerous virus in transplant patients